{
    "2021-10-30": [
        [
            {
                "time": "",
                "original_text": "复星医药：加大科研投入，持续加强商业化能力",
                "features": {
                    "keywords": [
                        "复星医药",
                        "科研投入",
                        "商业化能力"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "明看并购｜复星医药：文艺复“星”",
                "features": {
                    "keywords": [
                        "复星医药",
                        "并购",
                        "文艺复兴"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            }
        ]
    ]
}